HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The basal and the mutagen-induced levels of ADP-ribosyl transferase activity are not modified in Fanconi's anemia cells.

Abstract
The activity of ADP-ribosyl transferase, an enzyme thought to be involved in several basic functions of the chromatin and in DNA repair, has been investigated in normal and Fanconi's anemia (FA) cells. Fibroblasts and lymphoblasts treated with alkylating (dimethyl sulfate) or cross-linking (mitomycin C, psoralen plus UVA) agents were compared to untreated cells. The basal level of the enzymatic activity was found to be the same in normal and FA cells and the enzymatic response to treatments with DNA-damaging agents was similar in both cell types. Consequently it is unlikely that the molecular defect in FA cells is due to a decreased activity in ADP-ribosyl transferase.
AuthorsA I Scovassi, M Stefanini, R Izzo, P Lagomarsini, U Bertazzoni, E Moustacchi
JournalMutation research (Mutat Res) 1989 Jan-Feb Vol. 225 Issue 1-2 Pg. 65-9 ISSN: 0027-5107 [Print] Netherlands
PMID2492368 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Mitomycins
  • Mutagens
  • Sulfuric Acid Esters
  • Sulfuric Acids
  • Mitomycin
  • Poly(ADP-ribose) Polymerases
  • dimethyl sulfate
  • Methoxsalen
Topics
  • Anemia, Aplastic (enzymology)
  • Cell Line
  • DNA Replication (drug effects)
  • Fanconi Anemia (enzymology)
  • Humans
  • Lymphocytes (enzymology)
  • Methoxsalen (pharmacology)
  • Mitomycin
  • Mitomycins (pharmacology)
  • Mutagens (pharmacology)
  • Poly(ADP-ribose) Polymerases (metabolism)
  • Reference Values
  • Skin (enzymology)
  • Sulfuric Acid Esters (pharmacology)
  • Sulfuric Acids (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: